Abstract-Hypertrophied myocardium is associated with reductions in the transient outward K ϩ current (Ito) and expression of pore-forming Kv4.2/4.3 and auxiliary KChIP2 subunits. Here we show that KChIP2 mRNA and protein levels are dramatically decreased to 10% to 30% of control levels in the left ventricle of aorta-constricted rats in vivo and phenylephrine (PE)-treated myocytes in vitro. PE also markedly decreases Ito density. Inhibition of protein kinase Cs (PKCs) does not affect the PE-induced reduction in KChIP2 mRNA level, whereas activation of PKC with phorbol ester (phorbol myristate [PMA]) causes a marked reduction in KChIP2 mRNA level. Pharmacological inhibition of MEKs or overexpression of a dominant-negative MEK1 increases the basal KChIP2 mRNA expression and blocks the PMA-induced decrease in auxiliary subunit mRNA level. In addition, a constitutively active MEK1 decreases the basal KChIP2 mRNA level, and PMA causes no further reduction in auxiliary subunit mRNA level in active MEK1-expressing cells. Furthermore, pharmacological inhibition of JNKs or overexpression of a dominant-negative JNK1 prevents the PE-induced, but not PMA-induced, reduction in KChIP2 mRNA expression. These results suggest that downregulation of KChIP2 expression significantly contributes to the hypertrophy-associated reduction in Ito density. They also indicate that the expression of KChIP2 mRNA is controlled by the 2 branches of mitogen-activated protein kinase pathways: JNKs play a predominant role in mediating the PE-induced reduction, whereas the MEK-ERK pathway influences the basal expression and mediates the PKC-mediated downregulation. ardiac hypertrophy develops as a biological compensatory change in response to increased workload. However, sustained hypertrophy is a major risk factor for cardiac morbidity and mortality. 1,2 One of the commonly observed changes in hypertrophied myocardium is a reduction in transient outward K ϩ current (Ito). 3 Although it remains uncertain whether and how this reduction contributes to the increased cardiac dysfunction and sudden death seen with patients with hypertrophy, recent studies suggest that a marked reduction in Ito can be detrimental. For example, Ito is differentially expressed in distinct parts of the heart. 4 -11 Elimination of this differential expression may result in electrical instability by diminishing regional differences in action potential. 12 Likewise, decreased Ito can facilitate the development of cardiac hypertrophy by prolonging action potential duration and a window for Ca 2ϩ entry. 13,14 Thus, an uncontrolled decline in Ito channel expression may directly or indirectly participate in the induction of hypertrophy-associated pathological changes of the heart. Although Kv1.4-containing Kv1-family channels contribute to cardiac Ito, a large portion of the current is attributable to channels in the Kv4 family. 15
Materials and Methods
Animals and Neonatal Myocyte CultureAbdominal aortic constriction or sham operation was performed on male Sprague-Dawley rats (1...